Literature DB >> 12007211

In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses.

P Sepulveda1, J R Jones, L L Hench.   

Abstract

Effects of powder type, particle size (5-20 microm; 90-300 microm; 90-710 microm), and type of dissolution medium on the dissolution behavior of bioactive glasses were investigated in vitro using melt-derived 45S5 and sol-gel derived 58S bioactive glass powders. Dissolution studies were performed in simulated body fluid and in alpha-MEM based cell culture medium at 37 degrees C under dynamic conditions (1 Hz) for periods of 30 min, 1, 2, 4, 8, 17, and 22 h. The concentrations of elements dissolved from the glasses were evaluated using inductively coupled plasma analysis. The reacted powders were analyzed for bioactivity using Fourier transform infrared spectrometry to observe the formation of a calcium phosphate layer on the surface. The non-porous surfaces of melt-derived 45S5 glass powders exhibited lower dissolution rates and rate of surface layer formation than 58S gel-glass powders. The rates of dissolution for both types of powders were lower in culture medium, compared to simulated body fluid, and increased as the particle size decreased. Thus, particle size range, glass type, and powder volume fraction can be used as a means to control the release rate of active ions that stimulate the gene expression and cellular response for tissue proliferation and repair. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007211     DOI: 10.1002/jbm.10207

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  43 in total

1.  Bioactivity of degradable polymer sutures coated with bioactive glass.

Authors:  Oana Bretcanu; Enrica Verné; Luisa Borello; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2004-08       Impact factor: 3.896

2.  The bio-functional role of calcium in mesoporous silica xerogels on the responses of osteoblasts in vitro.

Authors:  Huanjun Zhou; Jie Wei; Xiaohui Wu; Jianlin Shi; Changsheng Liu; Junfeng Jia; Chenglong Dai; Qi Gan
Journal:  J Mater Sci Mater Med       Date:  2010-04-22       Impact factor: 3.896

3.  Comparison between the in vitro surface transformations of AP40 and RKKP bioactive glasses.

Authors:  A Krajewski; A Ravaglioli; A Tinti; P Taddei; M Mazzocchi; R Martinetti; C Fagnano; M Fini
Journal:  J Mater Sci Mater Med       Date:  2005-02       Impact factor: 3.896

4.  Primary osteoblast cell response to sol-gel derived bioactive glass foams.

Authors:  P Valerio; M H R Guimaráes; M M Pereira; M F Leite; A M Goes
Journal:  J Mater Sci Mater Med       Date:  2005-09       Impact factor: 3.896

5.  The story of Bioglass.

Authors:  Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

6.  Historic and current strategies in bone tissue engineering: do we have a hope in Hench?

Authors:  Eileen Gentleman; Julia M Polak
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

7.  Controlling ion release from bioactive glass foam scaffolds with antibacterial properties.

Authors:  Julian R Jones; Lisa M Ehrenfried; Priya Saravanapavan; Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

8.  Bioactive glass coatings affect the behavior of osteoblast-like cells.

Authors:  Silvia Foppiano; Sally J Marshall; Grayson W Marshall; Eduardo Saiz; Antoni P Tomsia
Journal:  Acta Biomater       Date:  2007-04-26       Impact factor: 8.947

9.  Sol-gel derived 45S5 bioglass: synthesis, microstructural evolution and thermal behaviour.

Authors:  Ilaria Cacciotti; Mariangela Lombardi; Alessandra Bianco; Antonio Ravaglioli; Laura Montanaro
Journal:  J Mater Sci Mater Med       Date:  2012-05-12       Impact factor: 3.896

10.  Microstructure and chemistry affects apatite nucleation on calcium phosphate bone graft substitutes.

Authors:  Charlie R Campion; Sara L Ball; Daniel L Clarke; Karin A Hing
Journal:  J Mater Sci Mater Med       Date:  2012-12-16       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.